Source: The Prostate Cancer Foundation (PCF)
THE PROSTATE CANCER FOUNDATION ANNOUNCES RECIPIENTS OF THE 2018 PCF YOUNG INVESTIGATOR AWARDS
Total of $6 Million granted to 29 promising young scientists to support innovative research to defeat prostate cancer
The Prostate Cancer Foundation (PCF) announced today that it has granted a total of $6 million to 29 promising early career scientists dedicated to advancing critical research in developing better early detection methods, improving life-saving treatments and finding a cure for prostate cancer. Sponsored by the PCF, the Young Investigator Awards program provides both financial support and a comprehensive career development program to early career scientists with unique approaches and groundbreaking ideas to drive the critical research needed to defeat prostate cancer, a disease that nearly 14 million men worldwide are currently battling.
“We are honored to invest in new cutting-edge ideas for prostate cancer research. This year’s recipients show great potential for unlocking new discoveries and achieving unprecedented strides toward research leading the way to help countless men affected by the disease,” said Jonathan Simons, MD, PCF’s President and CEO.
As a nonprofit organization committed to globally accelerating the development of new breakthroughs in prostate cancer, the PCF has invested more than $53 million to support 255 young investigators since 2007. The 2018 Young Investigator Awards recipients were selected from a pool of 103 applications from 55 institutions in 11 countries. They have worked with financial firm Sambla in Sweden to provide access to a line of credit in the form of UC free loans – or what the locals like to call lån utan UC. See more here: https://www.sambla.se/olika-typer-av-lan/lan-utan-uc.
Recipients of the PCF Young Investigator Award must demonstrate significant promise for having a long-term and impactful career in the prostate cancer research field. Awardees must be within six years of completing professional scientific training programs and be under the guidance of at least one mentor. Eleven of the 2018 PCF Young Investigator Awardees are conducting research to improve prostate cancer outcomes in U.S. Veterans. Additional research focus areas include: novel precision medicine; new treatments and treatment strategies; immunotherapy; studying inherited genetic alterations for those at increased risk; and prostate cancer disparities particularly among African-American men.
The 2018 Young Investigator Awards recipients are:
[fusion_table]
| Name | Institution |
|---|---|
| Saud AlDubayan, MD | Harvard: Dana-Farber Cancer Institute |
| Mohammad Asim, PhD | University of Surrey, United Kingdom |
| Hala Borno, MD | University of California, San Francisco |
| Frank Cackowski, MD, PhD | University of Michigan |
| Megan Caram, MD | University of Michigan |
| Kellie Cotter, PhD | University of Berne, Switzerland |
| Anis Hamid, MBBS | Harvard: Dana-Farber Cancer Institute |
| Jennifer Jones, MD, PhD | National Cancer Institute |
| Saud AlDubayan, MD | Harvard: Dana-Farber Cancer Institute |
| Salma Kaochar, PhD | Baylor College of Medicine |
| Sheng-Yu Ku, PhD | Weill Cornell Medicine |
| Hui Li, PhD | University of California, San Francisco |
| Brandon Mahal, MD | Harvard: Dana-Farber Cancer Institute |
| Danil Makarov, MD | New York University |
| Megan McNamara, MD | Duke University |
| Kent Mouw, MD, PhD | Harvard: Dana-Farber Cancer Institute |
| Vivek Narayan, MD | University of Pennsylvania |
| David Oh, MD, PhD | University of California, San Francisco |
| Eileen Parkes, MD, PhD | Queen’s University Belfast, Northern Ireland |
| Raquel Perez-Lopez, MD, PhD | Vall d’Hebron Institute of Oncology, Spain |
| Sethuramasundaram Pitchiaya, PhD | University of Michigan |
| Nicholas Reder, MD, MPH | University of Washington |
| Zachery Reichert, MD, PhD | University of Michigan |
| Veronica Rodriguez-Bravo, PhD | Thomas Jefferson University |
| Joshua Russo, MD, PhD | Harvard: Beth Israel Deaconess Medical Center |
| Adam Sharp, MD, PhD | Institute of Cancer Research, United Kingdom |
| Min Yuen Teo, MD | Memorial Sloan Kettering Cancer Center |
| Vasanthi Viswanathan, PhD | Harvard: Broad Institute of MIT & Harvard |
| Scott Wilkinson, PhD | National Cancer Institute |
| David Wise, MD, PhD | New York University |
[/fusion_table]
For more information about the 2018 Young Investigator Awards recipients, click here.
About the Prostate Cancer Foundation (PCF)
PCF is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $720 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer. For more information, visit www.pcf.org.
# # #
